Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RM

Ryan E. Michael — 9 Patents

CTC4 Therapeutics: 8 patents #10 of 35Top 30%
Erie, CO: #74 of 421 inventorsTop 20%
Colorado: #5,216 of 40,980 inventorsTop 15%
Overall (All Time): #535,341 of 4,157,543Top 15%
9 Patents All Time
Ryan E. Michael has been granted 9 US patents while listed as an inventor at C4 Therapeutics. The first was granted in 2020 and the most recent in December 2025. Ryan E. Michael ranks #535,341 of 4,157,543 US inventors in our database (top 12.9%). Patent records list Ryan E. Michael in Erie, CO, US.

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12486290 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Yeon AHN, Alexander Hird, Kiel Lazarski +5 more 2025-12-02
12371442 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Kiel Lazarski +5 more 2025-07-29
12076405 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Mark Fitzgerald +1 more 2024-09-03 $19,767,000
12048748 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Kiel Lazarski 2024-07-30 $6,877,000
11673902 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Kiel Lazarski +5 more 2023-06-13 $2,984,000
11185592 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Kiel Lazarski 2021-11-30 $26,267,000
10905768 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Yanke Liang, Mark Fitzgerald +1 more 2021-02-02 $31,729,000
10660968 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Yanke Liang, Kiel Lazarski 2020-05-26
10646575 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Yanke Liang, Mark Fitzgerald +1 more 2020-05-12